209 related articles for article (PubMed ID: 9125592)
1. Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity.
Quakyi EK; Hochstein HD; Tsai CM
Infect Immun; 1997 May; 65(5):1972-9. PubMed ID: 9125592
[TBL] [Abstract][Full Text] [Related]
2. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock.
Quakyi EK; Frasch CE; Buller N; Tsai CM
J Infect Dis; 1999 Sep; 180(3):747-54. PubMed ID: 10438363
[TBL] [Abstract][Full Text] [Related]
3. Immunization with meningococcal membrane-bound lipooligosaccharide accelerates granulocyte recovery and enhances lymphocyte proliferation in myelosuppressed mice.
Quakyi EK; Carter PH; Tsai CM; Marti GE
Pathobiology; 1997; 65(1):26-38. PubMed ID: 9200187
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
[TBL] [Abstract][Full Text] [Related]
5. Outer membrane vesicles from Neisseria meningitidis: effects on cytokine production in human whole blood.
Mirlashari MR; Høiby EA; Holst J; Lyberg T
Cytokine; 2001 Jan; 13(2):91-7. PubMed ID: 11145848
[TBL] [Abstract][Full Text] [Related]
6. Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis.
Gerritzen MJH; Martens DE; Uittenbogaard JP; Wijffels RH; Stork M
Sci Rep; 2019 Mar; 9(1):4716. PubMed ID: 30886228
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A
Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703
[TBL] [Abstract][Full Text] [Related]
8. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
[TBL] [Abstract][Full Text] [Related]
9. Differential role of lipooligosaccharide of Neisseria meningitidis in virulence and inflammatory response during respiratory infection in mice.
Zarantonelli ML; Huerre M; Taha MK; Alonso JM
Infect Immun; 2006 Oct; 74(10):5506-12. PubMed ID: 16988225
[TBL] [Abstract][Full Text] [Related]
10. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.
Zariri A; Beskers J; van de Waterbeemd B; Hamstra HJ; Bindels TH; van Riet E; van Putten JP; van der Ley P
Infect Immun; 2016 Oct; 84(10):3024-33. PubMed ID: 27481244
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.
Sanders H; Feavers IM
Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800
[TBL] [Abstract][Full Text] [Related]
13. CD46 accelerates macrophage-mediated host susceptibility to meningococcal sepsis in a murine model.
Wang X; Zhang D; Sjölinder M; Wan Y; Sjölinder H
Eur J Immunol; 2017 Jan; 47(1):119-130. PubMed ID: 27794168
[TBL] [Abstract][Full Text] [Related]
14. Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.
John CM; Phillips NJ; Din R; Liu M; Rosenqvist E; Høiby EA; Stein DC; Jarvis GA
J Biol Chem; 2016 Feb; 291(7):3224-38. PubMed ID: 26655715
[TBL] [Abstract][Full Text] [Related]
15. Induction of endotoxin tolerance by pathogenic Neisseria is correlated with the inflammatory potential of lipooligosaccharides and regulated by microRNA-146a.
Liu M; John CM; Jarvis GA
J Immunol; 2014 Feb; 192(4):1768-77. PubMed ID: 24442429
[TBL] [Abstract][Full Text] [Related]
16. Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them.
Holst J
Hum Vaccin; 2007; 3(6):290-4. PubMed ID: 17712231
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin).
Kahler CM; Stephens DS
Crit Rev Microbiol; 1998; 24(4):281-334. PubMed ID: 9887366
[TBL] [Abstract][Full Text] [Related]
18. Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component.
Sheerin D; O'Connor D; Dold C; Clutterbuck E; Attar M; Rollier CS; Sadarangani M; Pollard AJ
Sci Rep; 2019 Sep; 9(1):13797. PubMed ID: 31551511
[TBL] [Abstract][Full Text] [Related]
19. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.
Lehmann AK; Halstensen A; Aaberge IS; Holst J; Michaelsen TE; Sornes S; Wetzler LM; Guttormsen H
Infect Immun; 1999 May; 67(5):2552-60. PubMed ID: 10225920
[TBL] [Abstract][Full Text] [Related]
20. Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.
O'dwyer CA; Reddin K; Martin D; Taylor SC; Gorringe AR; Hudson MJ; Brodeur BR; Langford PR; Kroll JS
Infect Immun; 2004 Nov; 72(11):6511-8. PubMed ID: 15501782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
